To export finished pharmaceutical formulations to Afghanistan, Indian pharmaceutical companies must navigate a structured registration process overseen by the Afghanistan Food and Drug Authority (AFDA). This process ensures that imported medicines meet the country's standards for quality, safety, and efficacy.
Application Submission: The registration process begins with the submission of a completed application form for each product, accompanied by a cover letter on the applicant company's official letterhead. If the applicant is an Afghan importing company, a letter of authorization from the manufacturing company is required. This letter should be on the manufacturer's original letterhead, dated, and signed by the president or deputy of the company. It must be sent via the official email address of the manufacturing company.
Dossier Requirements: The application must include a comprehensive dossier containing:
- Certificates: A Certificate of Pharmaceutical Product (CoPP) endorsed by the Ministry of Health, Ministry of Commerce, and Ministry of Foreign Affairs in the country of origin, and authenticated by the Afghanistan Embassy.
- Manufacturing and Product Information: Copies of the manufacturing license, product manufacturing license, and product registration certificate from at least one other country.
- Quality Control Documents: Certificates of Analysis (CoA) for at least two batches of the Active Pharmaceutical Ingredient (API) and three batches of the finished product, along with stability data.
Dossier Format: The dossier should adhere to the Common Technical Document (CTD) format, which is internationally recognized and facilitates the evaluation process. This format includes sections on administrative data, quality, non-clinical, and clinical information.
Approval Timeline and Fees: The approval timeline can vary based on the completeness of the application and the workload of the AFDA. While specific timelines and fees are not explicitly detailed in the available sources, applicants should anticipate a thorough evaluation process. It is advisable to consult directly with the AFDA or a local regulatory affairs consultant for the most accurate and current information.
